Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial

• Главные авторы: Hee-Yeon Shin (Автор), Tae-Bin Yim (Автор), Hye-Min Heo (Автор), Geon-Ho Jahng (Автор), Seungwon Kwon (Автор), Seung-Yeon Cho (Автор), Seong-Uk Park (Автор), Woo-Sang Jung (Автор), Sang-Kwan Moon (Автор), Chang-Nam Ko (Автор), Jung-Mi Park (Автор)
• Формат: ‌
• Опубликовано: BMC, 2022-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Background Amnestic mild cognitive impairment (aMCI) is often considered a precursor to Alzheimer's disease (AD) and represents a key therapeutic target for early intervention of AD. However, no treatments have been approved for MCI at present. Our previous pilot study has shown that K...